[1]
|
Makishima, M., Okamoto, A.Y., Repa, J.J., et al. (1999) Identification of a Nuclear Receptor for Bile Acids. Science, 284, 1362-1365. https://doi.org/10.1126/science.284.5418.1362
|
[2]
|
Parks, D.J., Blanchard, S.G., Bledsoe, R.K., et al. (1999) Bile Acids: Natural Ligands for an Orphan Nuclear Receptor. Science, 284, 1365-1368. https://doi.org/10.1126/science.284.5418.1365
|
[3]
|
Wang, H., Chen, J., Hollister, K., Sowers, L.C. and Forman, B.M. (1999) Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR. Molecular Cell, 3, 543-553. https://doi.org/10.1016/S1097-2765(00)80348-2
|
[4]
|
Forman, B.M., Goode, E., Chen, J., et al. (1995) Identification of a Nuclear Receptor That Is Activated by Farnesol Metabolites. Cell, 81, 687-693. https://doi.org/10.1016/0092-8674(95)90530-8
|
[5]
|
Teodoro, J.S., Rolo, A.P. and Palmeira, C.M. (2011) Hepatic FXR: Key Regulator of Whole-Body Energy Metabolism. Trends in Endocrinology & Metabolism, 22, 458-466. https://doi.org/10.1016/j.tem.2011.07.002
|
[6]
|
Wang, Y.D., Chen, W.D., Moore, D.D. and Huang, W.D. (2008) FXR: A Metabolic Regulator and Cell Protector. Cell Research, 18, 1087-1095. https://doi.org/10.1038/cr.2008.289
|
[7]
|
Lee, F.Y., Lee, H., Hubbert, M.L., et al. (2006) FXR, a Multipurpose Nuclear Receptor. Trends in Biochemical Sciences, 31, 572-580. https://doi.org/10.1016/j.tibs.2006.08.002
|
[8]
|
Paik, D., Yao, L., Zhang, Y., et al. (2022) Human Gut Bacteria Produce ΤΗ17-Modulating Bile Acid Metabolites. Nature, 603, 907-912. https://doi.org/10.1038/s41586-022-04480-z
|
[9]
|
Funabashi, M., Grovet, L., Wang, M., et al. (2020) A Metabolic Pathway for Bile Acid Dehydroxylation by the Gut Microbiome. Nature, 582, 566-570. https://doi.org/10.1038/s41586-020-2396-4
|
[10]
|
Arab, J.P., Karpen, S.J., Dawson, P.A., et al. (2017) Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives. Hepatology, 65, 350-362. https://doi.org/10.1002/hep.28709
|
[11]
|
Joyce, S.A. and Gahan, C.G. (2017) Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota. Digestive Diseases, 35, 169-177. https://doi.org/10.1159/000450907
|
[12]
|
Xie, X., Dong, J., Lu, G., et al. (2020) Increased Circulating Total Bile Acid Levels Were Associated with Organ Failure in Patients with Acute Pancreatitis. BMC Gastroenterology, 20, Article No. 222. https://doi.org/10.1186/s12876-020-01243-w
|
[13]
|
Ahmad, T.R. and Haeusler, R.A. (2019) Bile Acids in Glucose Metabolism and Insulin Signalling—Mechanisms and Research Needs. Nature Reviews Endocrinology, 15, 701-712. https://doi.org/10.1038/s41574-019-0266-7
|
[14]
|
Qiu, Y., Shen, L., Fu, L., et al. (2020) The Glucose-Lowering Effects of α-Glucosidase Inhibitor Require a Bile Acid Signal in Mice. Diabetologia, 63, 1002-1016. https://doi.org/10.1007/s00125-020-05095-7
|
[15]
|
Van De Wiel, S.M.W., Bijsmans, I.T.G.W., Van Mil, S.W.C., et al. (2019) Identification of FDA-Approved Drugs Targeting the Farnesoid X Receptor. Scientific Reports, 9, Article No. 2193. https://doi.org/10.1038/s41598-019-38668-7
|
[16]
|
Wan, Y.D., Zhu, R.X., Pan, X.T. and Sun, T.W. (2020) Bile Acid Supplementation Improves Murine Pancreatitis in Association with the Gut Microbiota. Frontiers in Physiology, 11, Article 650. https://doi.org/10.3389/fphys.2020.00650
|
[17]
|
Martinot, E., Sèdes, L., Baptissart, M., et al. (2017) Bile Acids and Their Receptors. Molecular Aspects of Medicine, 56, 2-9. https://doi.org/10.1016/j.mam.2017.01.006
|
[18]
|
Taoka, H., Yokoyama, Y., Morimoto, K., et al. (2016) Role of Bile Acids in the Regulation of the Metabolic Pathways. World Journal of Diabetes, 7, 260-270. https://doi.org/10.4239/wjd.v7.i13.260
|
[19]
|
Gonzalez, F.J. (2012) Nuclear Receptor Control of Enterohepatic Circulation. Comprehensive Physiology Nuclear Receptor Control of Enterohepatic Circulation, 2, 2811-2828. https://doi.org/10.1002/cphy.c120007
|
[20]
|
Ovadia, C., Perdones-Montero, A., Spagou, K., et al. (2019) Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis. Hepatology, 70, 276-293. https://doi.org/10.1002/hep.30661
|
[21]
|
Cao, Y., Xiao, Y., Zhou, K., et al. (2019) FXR Agonist GW4064 Improves Liver and Intestinal Pathology and Alters Bile Acid Metabolism in Rats Undergoing Small Intestinal Resection. American Journal of Physiology-Gastrointestinal and Liver Physiology, 317, G108-G115. https://doi.org/10.1152/ajpgi.00356.2017
|
[22]
|
Jiang, L., Zhang, H., Xiao, D., et al. (2021) Farnesoid X Receptor (FXR): Structures and Ligands. Computational and Structural Biotechnology Journal, 19, 2148-2159. https://doi.org/10.1016/j.csbj.2021.04.029
|
[23]
|
Panzitt, K. and Wagner, M. (2021) FXR in Liver Physiology: Multiple Faces to Regulate Liver Metabolism. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1867, Article ID: 166133. https://doi.org/10.1016/j.bbadis.2021.166133
|
[24]
|
高冬梅, 乔明琦, 张惠云, 等. 经前期综合征肝气郁证猕猴模型评价指标[J]. 中医杂志, 2005, 46(12): 931-933. https://doi.org/10.13288/J.11-2166/R.2005.12.036
|
[25]
|
王海军, 乔明琦, 张惠云. 经前期综合征(PMS)肝气逆证猕猴造模及用药血清中性激素检测与分析[J]. 中药药理与临床, 2006, 22(5): 58-59.
|
[26]
|
Jia, W., Xie, G. and Jia, W. (2018) Bile Acid-Microbiota Crosstalk in Gastrointestinal Inflammation and Carcinogenesis. Nature Reviews Gastroenterology & Hepatology, 15, 111-128. https://doi.org/10.1038/nrgastro.2017.119
|
[27]
|
张惠云, 乔明琦, 孙丽. 肝气郁证模型大鼠下丘脑单胺类神经递质分析[J]. 中医杂志, 2008, 49(2): 150-152.
|
[28]
|
Mahmoudian Dehkordi, S., Arnold, M., Nho, K., et al. (2019) Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s Disease—An Emerging Role for Gut Microbiome. Alzheimer’s & Dementia, 15, 76-92.
|
[29]
|
Holmqvist, S., Chutna, O., Bousset, L., et al. (2014) Direct Evidence of Parkinson Pathology Spread from the Gastrointestinal Tract to the Brain in Rats. Acta Neuropathologica, 128, 805-820. https://doi.org/10.1007/s00401-014-1343-6
|
[30]
|
Kim, D.G., Krenz, A., Toussaint, L.E., et al. (2016) Non-Alcoholic Fatty Liver Disease Induces Signs of Alzheimer’s Disease (AD) in Wild-Type Mice and Accelerates Pathological Signs of AD in an AD Model. Journal of Neuroinflammation, 13, Article No. 1. https://doi.org/10.1186/s12974-015-0467-5
|
[31]
|
Zhang, X., Huang, S., Gao, M., et al. (2014) Farnesoid X Receptor (FXR) Gene Deficiency Impairs Urine Concentration in Mice. Proceedings of the National Academy of Sciences of the United States of America, 111, 2277-2282. https://doi.org/10.1073/pnas.1323977111
|
[32]
|
高慧, 王帅. 基于《内经》“木曰敷和”理论对动脉粥样硬化性疾病微探[J/OL]. 辽宁中医药大学学报: 1-8. https://doi.org/10.13194/j.issn.1673-842x.2023.03.017, 2022-10-27.
|
[33]
|
Miyazaki-Anzai, S., Masuda, M., Kohno, S., et al. (2018) Simultaneous Inhibition of FXR and TGR5 Exacerbates Atherosclerotic Formation. Journal of Lipid Research, 59, 1709-1713. https://doi.org/10.1194/jlr.M087239
|
[34]
|
Lauritsen, M.P., Bentzen, J.G., Pinborg, A., et al. (2014) The Prevalence of Polycystic Ovary Syndrome in a Normal Population According to the Rotterdam Criteria versus Revised Criteria Including Anti-Mullerian Hormone. Human Reproduction, 29, 791-801. https://doi.org/10.1093/humrep/det469
|
[35]
|
Yang, Y.L., Zhou, W.W., Wu, S., et al. (2021) Intestinal Flora Is a Key Factor in Insulin Resistance and Contributes to the Development of Polycystic Ovary Syndrome. Endocrinology, 162, bqab118. https://doi.org/10.1210/endocr/bqab118
|
[36]
|
李云, 刘天宇, 张文军. 肝肠法尼酯X受体在代谢性疾病中的作用研究进展[J]. 天津药学, 2023, 35(1): 71-78.
|
[37]
|
Kaeding, J., Bouchaert, E., Bélanger, J., et al. (2008) Activators of the Farnesoid X Receptor Negatively Regulate Androgen Glucuronidation in Human Prostate Cancer LNCAP Cells. Biochemical Journal, 410, 245-253. https://doi.org/10.1042/BJ20071136
|
[38]
|
Takae, K., Nakata, M., Watanabe, T., et al. (2019) Evidence for the Involvement of FXR Signaling in Ovarian Granulosa Cell Function. The Journal of Reproduction and Development, 65, 47-55. https://doi.org/10.1262/jrd.2018-054
|
[39]
|
Han, C.Y. (2018) Update on FXR Biology: Promising Therapeutic Target? International Journal of Molecular Sciences, 19, Article 2069. https://doi.org/10.3390/ijms19072069
|
[40]
|
Thomas, C., Pellicciari, R., Pruzanski, M., et al. (2008) Targeting Bile-Acid Signalling for Metabolic Diseases. Nature Reviews Drug Discovery, 7, 678-693. https://doi.org/10.1038/nrd2619
|